"10.1371_journal.pone.0109679","plos one","2014-10-06T00:00:00Z","Claudia Borreani; Elisabetta Bianchi; Erika Pietrolongo; Ilaria Rossi; Sabina Cilia; Miranda Giuntoli; Andrea Giordano; Paolo Confalonieri; Alessandra Lugaresi; Francesco Patti; Maria Grazia Grasso; Laura Lopes de Carvalho; Lucia Palmisano; Paola Zaratin; Mario Alberto Battaglia; Alessandra Solari; on behalf of the PeNSAMI project","Unit of Psychology, Foundation IRCCS Istituto Nazionale per la Cura dei Tumori, Milan, Italy; Department of Neuroscience, Imaging and Clinical Sciences, University G. dAnnunzio of Chieti-Pescara, Chieti, Italy; Multiple Sclerosis Unit, Foundation IRCCS S. Lucia Rehabilitation Hospital, Rome, Italy; Neurology Clinic, MS Center, University Hospital Policlinico Vittorio Emanuele, Catania, Italy; AISM Liguria Region Rehabilitation Service, Genoa, Italy; Unit of Neuroepidemiology, Foundation IRCCS Neurological Institute C. Besta, Milan, Italy; Unit of Neuroimmunology, Foundation IRCCS Neurological Institute C. Besta, Milan, Italy; Dept. of Therapeutic Research and Medicine Evaluation, Istituto Superiore di Sanità, Rome, Italy; Scientific Research Department, Italian Multiple Sclerosis Foundation, Genoa, Italy","Conceived and designed the experiments: CB AG LLC LP PZ MAB AS. Performed the experiments: EB EP IR SC MG PC AL FP MGG LLC. Analyzed the data: CB EB. Wrote the paper: CB EB EP IR SC MG AG PC AL FP MGG LLC LP PZ MAB AS.","I have read the journals policy and the authors of this manuscript have the following competing interests: EP has received travel grants from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and Teva and also received travel and research grants from the Fondazione Italiana Sclerosi Multipla. PC has been a board member of Biogen-idec, received travel grants from Sanofi Aventis, Biogen Dompé AG and Merk Serono. AL has been a Bayer Schering, Biogen Idec, Merck Serono and Genzyme advisory board member. She received travel grants and honoraria from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and Teva and research grants from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and Teva. She has also received travel and research grants from the Associazione Italiana Sclerosi Multipla and was a consultant of Fondazione Cesare Serono. FP received honoraria for speaking activities from Bayer Schering, Biogen Idec, Merck Serono, Novartis, and Sanofi Aventis. He has served as advisory board member of the following companies: Bayer Schering, Biogen Idec, Merck Serono, and Novartis. MGG has received research funding from Merck Serono and consulting and speaking fees from Biogen Idec. AS has been a board member of Biogen Idec and Novartis, and has received speaker honoraria from Genzyme, Merck Serono and the Fondazione Serono. The authors confirm that this declaration does not alter the authors adherence to all PLOS ONE policies on sharing data and materials.","2014","10","Claudia Borreani","CB",17,TRUE,7,10,2,16,TRUE,TRUE,TRUE,1,"17",TRUE
